Investment Update
Recommendation: Buy the script as it presents a favorable opportunity for upside potential.
Upside Potential: Expecting a 16–20% rise within the next 1–2 months.
Target Levels:
Initial Target: ₹18
Secondary Target: ₹21
Stop-Loss (SL): Place a stop-loss at ₹15 to manage risk effectively.
Rationale: Despite its recent underperformance, the script belongs to a fundamentally strong company and is poised for a rebound.
Recommendation: Buy the script as it presents a favorable opportunity for upside potential.
Upside Potential: Expecting a 16–20% rise within the next 1–2 months.
Target Levels:
Initial Target: ₹18
Secondary Target: ₹21
Stop-Loss (SL): Place a stop-loss at ₹15 to manage risk effectively.
Rationale: Despite its recent underperformance, the script belongs to a fundamentally strong company and is poised for a rebound.
交易开始
TRADE IS STILL ACTIVE 
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。